<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Approved drugs used in COVID-19 repurpose clinical trials.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Category</th>
    <th>Drug name</th>
    <th>Approved indication</th>
    <th>Mechanism</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="4">Biomacro-molecule</td>
    <td>Tocilizumab</td>
    <td>Rheumatoid arthritis</td>
    <td>IL-6R antibody</td>
   </tr>
   <tr>
    <td>Type I interferon (include IFN-α &amp; IFN-β)</td>
    <td>Hairy cell leukemia, melanoma, AIDS-related Kaposi’s sarcoma</td>
    <td>Immune modulation</td>
   </tr>
   <tr>
    <td>Thymosin a1</td>
    <td>T cell defect, autoimmunity disease</td>
    <td>T cell stimulation</td>
   </tr>
   <tr>
    <td>rhG-CSF</td>
    <td>Leukopenia</td>
    <td>CSF receptor</td>
   </tr>
   <tr>
    <td rowspan="26">Chemical Agent</td>
    <td>Lopinavir/ritonavir</td>
    <td>HIV</td>
    <td>HIV-1 protease inhibitor</td>
   </tr>
   <tr>
    <td>Emtritabine</td>
    <td>HIV</td>
    <td>Reverse transcriptase inhibitor</td>
   </tr>
   <tr>
    <td>Azvudine</td>
    <td>HIV</td>
    <td>Reverse transcriptase inhibitor</td>
   </tr>
   <tr>
    <td>Ribavirin</td>
    <td>HCV</td>
    <td>RdRp
     <sup>a</sup> inhibitor
    </td>
   </tr>
   <tr>
    <td>Danorevir</td>
    <td>HCV</td>
    <td>HCV protease inhibitor</td>
   </tr>
   <tr>
    <td>Ganovo</td>
    <td>HCV</td>
    <td>HCV protease inhibitor</td>
   </tr>
   <tr>
    <td>Tenofovir</td>
    <td>HBV</td>
    <td>Reverse transcriptase inhibitor</td>
   </tr>
   <tr>
    <td>Triazavirin</td>
    <td>Flu</td>
    <td>RdRp inhibitor</td>
   </tr>
   <tr>
    <td>Favipiravir</td>
    <td>Flu</td>
    <td>RdRp inhibitor</td>
   </tr>
   <tr>
    <td>Baloxavir Marboxil</td>
    <td>Flu</td>
    <td>Influenza virus cap-dependent endonuclease inhibitor</td>
   </tr>
   <tr>
    <td>Arbidol</td>
    <td>Flu</td>
    <td>Virion entry inhibitor</td>
   </tr>
   <tr>
    <td>Poly (I:C) Injection</td>
    <td>Viral infection</td>
    <td>Immune modulation</td>
   </tr>
   <tr>
    <td>Carrimycin</td>
    <td>Bacteria infection</td>
    <td>Peptide acyltransferase inhibitor</td>
   </tr>
   <tr>
    <td>Dihydroartemisinine/Piperaquine</td>
    <td>Malaria</td>
    <td>Multiple targets</td>
   </tr>
   <tr>
    <td>Chloroquine
     <sup>b</sup>
    </td>
    <td>Malaria</td>
    <td>Heme biocrystallization inhibitor</td>
   </tr>
   <tr>
    <td>Suramin</td>
    <td>Trypanosomes infection</td>
    <td>Multiple targets</td>
   </tr>
   <tr>
    <td>Ruxolitinib</td>
    <td>Myelofibrosis</td>
    <td>JAK1/JAK2 signaling inhibition</td>
   </tr>
   <tr>
    <td>Leflunomide</td>
    <td>Rheumatoid arthritis</td>
    <td>Pyrimidine synthesis inhibitor</td>
   </tr>
   <tr>
    <td>Tranilast</td>
    <td>Bronchial asthma, Allergic disorders</td>
    <td>Hematopoietic prostaglandin D synthase inhibitor</td>
   </tr>
   <tr>
    <td>Ebastine</td>
    <td>Allergic rhinitis, Chronic idiopathic urticaria</td>
    <td>Histamine H
     <sub>1</sub>-receptor antagonist
    </td>
   </tr>
   <tr>
    <td>Alpha lipoic acid</td>
    <td>Diabetic multiple peripheral neuropathy</td>
    <td>Antioxidant</td>
   </tr>
   <tr>
    <td>Pirfenidone</td>
    <td>Idiopathic pulmonary fibrosis</td>
    <td>Collagen synthesis inhibition, Cytokine down-regulation</td>
   </tr>
   <tr>
    <td>Bismuth potassium citrate</td>
    <td>Gastric ulcer</td>
    <td>Gastric mucosa protectant</td>
   </tr>
   <tr>
    <td>Enoxaparin Sodium Injection</td>
    <td>Venous thromboembolic disease</td>
    <td>Xa factor inbihitor</td>
   </tr>
   <tr>
    <td>Glycyrrhizinate</td>
    <td>Premenstrual syndrome, Viral infections</td>
    <td>Multiple targets</td>
   </tr>
   <tr>
    <td>Glucocorticoid</td>
    <td>Inflammatory conditions</td>
    <td>Glucocorticoid receptor</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup>RdRp, RNA-dependent RNA polymerase.
  </p>
 </table-wrap-foot>
</table-wrap>
